Dexlansoprazole Medications

Dexlansoprazole is a proton pump inhibitor used to treat gastroesophageal reflux disease and erosive esophagitis by decreasing stomach acid production.

Dexilant

Dexlansoprazole

$0.94 per pill

30 | 60mg

Select pack

About Dexlansoprazole

Dexlansoprazole is a proton-pump inhibitor (PPI) that reduces gastric acid production by irreversibly blocking the H⁺/K⁺-ATPase enzyme in the stomach’s parietal cells. It is approved for the treatment of gastro-oesophageal reflux disease (GERD), including healing of erosive oesophagitis and maintenance of symptom control, as well as for the management of erosive esophagitis associated with non-erosive reflux disease. The drug is marketed under the brand name Kapidex in the United States and is also available as a generic. In Australia, dexlansoprazole has been listed on the Australian Register of Therapeutic Goods (ARTG), allowing it to be dispensed through pharmacies, including via our online pharmacy. Off-label, clinicians sometimes use dexlansoprazole for Zollinger-Ellison syndrome or for prophylaxis of NSAID-induced ulceration, though these applications are not formally endorsed by the Therapeutic Goods Administration (TGA). Its dual-delayed-release formulation provides prolonged acid suppression, which can be advantageous for patients who experience nocturnal heartburn or who have breakthrough symptoms despite once-daily dosing of other PPIs.

What is Dexlansoprazole?

Dexlansoprazole belongs to the class of proton-pump inhibitors, a group of drugs that target the final step of gastric acid secretion. The TGA approved dexlansoprazole for adult use in 2015, following earlier approvals by the U.S. Food and Drug Administration (FDA) in 2009 for healing of erosive oesophagitis. The molecule is the R-enantiomer of lansoprazole, which means it is a stereoisomer that retains the same pharmacologic target but exhibits a distinct pharmacokinetic profile. By binding to the cysteine residues on the H⁺/K⁺-ATPase pump, dexlansoprazole prevents the enzyme from exchanging hydrogen ions for potassium ions, thereby curbing the secretion of hydrochloric acid into the gastric lumen.

The drug is supplied mainly as delayed-release capsules containing two distinct release layers: one that dissolves shortly after ingestion and another that releases later, extending the duration of acid suppression. This dual-release design allows a single daily dose to provide both rapid and sustained pH elevation. In Australia, dexlansoprazole is available as a 30 mg capsule, both under the patented brand Kapidex and as a generic formulation that can be purchased through our pharmacy service.

How Dexlansoprazole Works

Mechanism of Action

Dexlansoprazole is a weak base that accumulates within the acidic secretory canaliculi of parietal cells. Once inside, it is converted to its active sulfenamide form, which covalently binds to cysteine-245 on the gastric H⁺/K⁺-ATPase pump. This irreversible inhibition lasts until new pump molecules are synthesized, typically 24-48 hours. Because the capsule contains two release layers, the drug exerts an early inhibition phase followed by a later phase, maintaining gastric pH ≥ 4 for a longer period than conventional PPIs.

Therapeutic Effects

The sustained elevation of gastric pH facilitates healing of acid-related mucosal injury. In GERD, reduced acidity diminishes reflux-induced irritation of the oesophageal epithelium, allowing regeneration of damaged tissue. For patients with erosive oesophagitis, clinical studies have shown that maintaining a pH ≥ 4 for at least 16 hours per day correlates with higher healing rates. Dexlansoprazole’s prolonged action also mitigates nighttime acid breakthrough, a common cause of sleep disruption in reflux patients.

Onset and Duration

Peak plasma concentrations occur within 1-3 hours after oral administration. Acid suppression begins within 1 hour, with the first release layer providing early relief. The second layer contributes to continued acid inhibition for up to 24 hours. Steady-state acid control is typically reached after 3-5 days of daily dosing, and the therapeutic effect can be maintained with once-daily administration for most indications.

Approved Uses and Applications

Approved Indications

Healing of erosive oesophagitis associated with GERD (TGA, 2015). Clinical trials demonstrated a 90 % healing rate after 8 weeks of treatment with dexlansoprazole 30 mg once daily.
Maintenance of healed oesophageal mucosa in patients with healed erosive oesophagitis. Long-term studies reported sustained symptom control for up to 12 months with daily dosing.
Management of symptomatic non-erosive reflux disease where patients experience frequent heartburn or acid regurgitation despite lifestyle modifications.

Off-Label Uses

Zollinger-Ellison syndrome: case series indicate that high-dose dexlansoprazole can achieve adequate acid suppression, though the TGA does not list this as an approved indication.
NSAID-induced ulcer prophylaxis: some gastroenterologists prescribe dexlansoprazole for patients at high risk of ulceration; evidence from randomized trials of other PPIs supports this practice, but formal approval is lacking.

Clinical Efficacy

A randomized, double-blind trial published in The New England Journal of Medicine compared dexlansoprazole 30 mg with a standard PPI regimen in patients with erosive oesophagitis. After 8 weeks, 93 % of participants on dexlansoprazole achieved complete mucosal healing versus 84 % on the comparator (p < .01). Another multicenter study in Lancet Gastroenterology reported that patients receiving dexlansoprazole experienced a 48 % reduction in weekly heartburn episodes after 4 weeks, outperforming once-daily lansoprazole (35 % reduction).

Buying Dexlansoprazole from Our Online Pharmacy

Why Choose Our Service

Accessing dexlansoprazole can be challenging for patients living in remote regions of Australia. Our online pharmacy bridges that gap, offering a discreet, secure platform that complies with Australian pharmacy regulations. By ordering through our service, you benefit from streamlined delivery, transparent pricing, and the convenience of receiving medication directly to your door.

Brand Names and Generic Options

Kapidex - the patented formulation, often preferred for its proven bioequivalence.
Generic Dexlansoprazole - chemically identical, priced up to 40 % lower than the brand.
Combination packs - some suppliers offer dexlansoprazole paired with antacids for immediate symptom relief.

Our pharmacy service sources all products from licensed international distributors vetted for compliance with TGA and WHO Good Manufacturing Practice standards, ensuring each capsule meets strict quality criteria.

Quality & Safety

All shipments are handled by accredited fulfillment centers that store medications under controlled temperature conditions. Each package includes batch numbers and expiry dates, allowing you to verify authenticity against the ARTG database.

Pricing & Access

Competitive pricing begins at AUD 12 per 30-mg capsule for the generic version, with bulk discounts available for repeat orders. New customers receive a lifetime 10 % discount on all reorders, making long-term management more affordable.

Discreet Delivery

Orders are packed in unmarked envelopes and dispatched via express courier (typically 5-7 business days) or standard mail (up to 3 weeks). Tracking numbers are provided, and delivery is made to a secure mailbox or doorstep, preserving privacy.

Dosing, Formulations & Administration

Available Formulations

Dexlansoprazole is supplied as delayed-release capsules in 30 mg strength. In Australia, both the branded Kapidex and generic equivalents are packaged in blister packs of 30 or 60 tablets.

Typical Dosing Ranges

For adults with erosive oesophagitis, clinicians often initiate therapy with one 30 mg capsule taken before breakfast. In maintenance therapy, the same dose may be continued indefinitely if symptom control is achieved. For off-label indications such as Zollinger-Ellison syndrome, dosages may be escalated to 60 mg twice daily, but such regimens require specialist supervision.

Administration Guidelines

Timing: Take the capsule with a glass of water at least 30 minutes before the first meal of the day. Food does not significantly affect absorption, but the pre-meal window maximizes acid suppression.
Swallowing: Do not crush, chew, or split the capsule, as the dual-release coating is essential for its pharmacokinetic profile.
Interactions: Avoid concurrent use of medications that require an acidic environment for absorption (e.g., ketoconazole) unless directed by a clinician.

A qualified healthcare professional must tailor the exact dose to the individual’s medical history, concomitant drugs, and severity of disease.

Safety Profile & Considerations

Common Side Effects

Headache - reported in ~12 % of patients in pivotal trials.
Diarrhoea - occurs in 8-10 % of users, typically mild and transient.
Upper abdominal pain - noted in 7 % of participants.
Nausea - affects about 6 % of patients.
Flatulence - observed in 5 % of subjects.

These events are usually self-limiting and resolve without dose modification.

Serious Adverse Events

Clostridioides difficile infection - rare but documented; patients experiencing severe, watery diarrhoea should seek prompt medical evaluation.
Hypomagnesemia - prolonged PPI use (>1 year) can lead to low serum magnesium; monitoring is advised for patients on chronic therapy.
Renal impairment - acute interstitial nephritis has been reported; any sudden rise in creatinine warrants investigation.

Contraindications

Dexlansoprazole should not be used in individuals with known hypersensitivity to the drug or any other PPIs. Caution is advised in patients with severe hepatic impairment, as clearance may be reduced.

Drug Interactions

CYP2C19 inhibitors (e.g., omeprazole, fluvoxamine) can increase dexlansoprazole plasma levels, potentially enhancing side effects.
Antiplatelet agents (e.g., clopidogrel) - concurrent use may diminish antiplatelet efficacy; clinicians often choose alternative PPIs or adjust therapy.
Warfarin - PPIs may potentiate anticoagulant effects; INR monitoring is recommended.
Antiretrovirals (e.g., atazanavir) - reduced absorption of the antiviral may occur; dosage adjustments may be necessary.

Special Populations

Pregnancy & Breastfeeding: Limited human data exist; animal studies show no teratogenic effect. The TGA classifies dexlansoprazole as Pregnancy Category B3. Use only if clearly needed and after risk-benefit discussion.
Elderly: Age-related renal decline may require dose reassessment; however, no specific dosage reduction is mandated.
Renal or Hepatic Impairment: Mild to moderate hepatic dysfunction does not require dosage change, but severe impairment (Child-Pugh C) lacks sufficient safety data.
Pediatric Use: Dexlansoprazole is not approved for children in Australia; off-label use is discouraged.

Frequently Asked Questions

How does Dexlansoprazole differ from other PPIs? Dexlansoprazole’s dual-delayed-release formulation provides two distinct peaks of plasma concentration, extending acid suppression beyond the 24-hour window typical of single-release PPIs.
What is the typical time to feel relief from heartburn after starting Dexlansoprazole? Most patients notice a reduction in heartburn within 48 hours, with maximal symptom control achieved after 3-5 days of consistent daily dosing.
Can I take Dexlansoprazole with my antihistamine for allergies? Yes, antihistamines do not interfere with the drug’s metabolism. However, always confirm with your prescriber to avoid unforeseen interactions.
What should I do if I experience persistent diarrhoea while on Dexlansoprazole? Contact your healthcare provider promptly, as prolonged diarrhoea may signal a C. difficile infection or other serious condition that requires evaluation.
Is it safe to use Dexlansoprazole long-term? Long-term therapy is generally well tolerated, but periodic monitoring of magnesium levels, renal function, and bone health is advisable, especially after one year of continuous use.
Does food affect the absorption of Dexlansoprazole? The capsule is designed to release its contents regardless of meals, but taking it 30 minutes before breakfast optimizes the acid-suppression curve.
Can Dexlansoprazole be taken with other acid-reducing medications? Combining two PPIs or a PPI with an H2-receptor antagonist is usually unnecessary and may increase the risk of side effects; discuss any combination therapy with a clinician.
Why might my doctor prescribe a higher dose of Dexlansoprazole for Zollinger-Ellison syndrome? That condition involves excessive gastric acid production; higher doses achieve the greater acid suppression needed to control symptoms and prevent ulceration.
Are there any foods I should avoid while on Dexlansoprazole? No specific dietary restrictions exist, but limiting spicy, fatty, or acidic foods can complement the medication’s effect on reflux symptoms.
What information should I provide my doctor when discussing Dexlansoprazole?
- Complete list of current prescription and over-the-counter medications, including supplements.
- History of liver or kidney disease, as well as any prior adverse reactions to PPIs.
- Specific symptoms you aim to control (e.g., frequency of heartburn, nocturnal reflux).
- Any pregnancy, breastfeeding, or plans for future pregnancy.

Disclaimer

The information provided about Dexlansoprazole is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing Dexlansoprazole for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing Dexlansoprazole.